(Reuters) – SIGA Technologies Inc on Thursday said it has won a new contract for its antiviral drug, Tpoxx, from the U.S. Department of Health and Human Services, sending the …
antiviral
-
-
(Reuters) – The National Institutes of Health (NIH) said on Friday it had started enrolling monkeypox patients in a late-stage study testing Siga Technologies Inc’s antiviral pill Tpoxx against the …
-
– Gilead Sciences Inc’s drug, remdesivir, showed antiviral activity against Omicron, Delta and other variants of the coronavirus in laboratory studies, the company said on Friday. The study results showed …
-
-British researchers want to repurpose existing antiviral therapies to treat COVID-19, the University of Oxford said on Friday, in an attempt to sidestep lengthy development processes through readily available drugs. …
-
The New York State Department of Health (NYS DOH) is requiring healthcare providers to prioritize non-white patients when administering oral antiviral treatment for COVID-19. The department issued a health advisory …
-
– The Biden administration is looking at ways to broaden access to potential COVID-19 antiviral pills when supply increases in the coming months, the Wall Street Journal reported on Friday, …
-
– The European Medicine Agency’s review to approve Merck’s antiviral pill molnupiravir, developed with Ridgeback Therapeutics, is set to conclude by the end of the year, the regulator’s head of …
-
By Michael Erman – Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults …
-
By Deena Beasley -Pfizer Inc’s experimental antiviral pill to treat COVID-19 cut by 89% the chance of hospitalization or death for adults at risk of severe disease, the company said …